STUDIES & RESEARCH

Oral Administration of the Growth Hormone Secretagogue MK-677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults

by Murphy et al.

VIEW ORIGINAL STUDY